In vitro characterization and in vivo release profile of a poly (D,L-lactide-co-glycolide)-based implant delivery system for the α-MSH analog, melanotan-I

International Journal of Pharmaceutics

Volumn 170, Issue 1, 1998, Pages 109-117

  Bhardwaj, R ^a   Blanchard, J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Controlled release; Melanotan I; Pharmacokinetics; Poly(D,L lactide co glycolide); Polymer degradation

Indexed keywords

COPOLYMER; INTERMEDIN DERIVATIVE; POLYGLACTIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED RELEASE FORMULATION; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG RELEASE; GUINEA PIG; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032143913     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00149-5     Document Type: Article

References (21)

1. Bhardwaj, R., Blanchard, J., 1997. In vitro evaluation of poly(DL-lactide-co-glycolide) polymer-based implants containing the α-melanocyte stimulating hormone analog, Melanotan-I. J. Control. Release 45, 49-55.
2. Bodmer, D., Kissel, T., Traechslin, E., 1992. Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. J. Control. Release 21, 129-137.
3. Castrucci, A.M., Hadley, M.E., Hruby, V.J., 1984. Melanotropin bioassays: in vitro and in vivo comparisons. Gen. Comp. Endocrinol. 55, 104-111.
4. Dutta, A.S., Furr, B.J.A., Hutchinson, F.G., 1993. Discovery and development of Goserelin (Zoladex®). Pharm. Med. 7, 9-28.
5. Furr, B.J.A., Hutchinson, F.G., 1992. A biodegradable delivery system for peptides: preclinical experience with the gonadotrophin-releasing hormone agonist Zoladex®. J. Control. Release 21, 117-127.
6. Grizzi, I., Garreau, H., Li, S., Vert, M., 1995. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. Biomaterials 16, 305-311.
7. Helder, J., Dijkstra, P.J., Feijen, J., 1990. In vitro degradation of glycine/DL-lactic acid copolymers. J. Biomed. Mater. Res. 24, 1005-1020.
8. Hausberger, A.G., DeLuca, P.P., 1995. Characterization of biodegradable poly(DL-lactide-co- glycolide) polymers and microspheres. J. Pharm. Biomed. Anal. 13, 747-760.
9. Kenley, A.A., Lee, M.O., Mahoney, T.R., Sanders, L.M., 1987. Poly(lactide-co-glycolide) decomposition kinetics in vivo and in vitro. Macromolecules 20, 2398-2403.
10. 7]α-MSH. Pigment Cell Res. 2, 65-69.
11. Krieger, D.T., Liotta, A.S., Brownstein, M.J., Zimmerman, E.A., 1980. ACTH, β-lipoprotein, and related peptides in brain, pituitary, and blood. Rec. Prog. Horm. Res. 36, 277-344.
12. Lewis D.H., 1990. Controlled release of bioactive agents from lactide/glycolide polymers. In: Chasin, M., Langer, R. (Eds), Biodegradable Polymers as Drug Delivery Systems. Marcel Dekker, New York, pp. 1-14.
13. Okada, H., Inoue, Y., Heya, T., Ueno, H., Ogawa, Y., Toguchi, H., 1991. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. Pharm. Res. 8, 787-791.
14. Park, T.G., 1995. Degradation of poly(lactic-co-glycolic acid) microspheres:effect of copolymer composition. Biomaterials 16, 1123-1130.
15. Sanders, L.M., Kent, J.S., McRae, G.I., Vickery, B.H., Tice, T.R., Lewis, D.H., 1984. Controlled release of luteinizing hormone-releasing analogue from the poly(DL-lactide-co-glycolide) microspheres. J. Pharm. Sci. 73, 1294-1297.
16. Sanders, L.M., Kell, B.A., McRae, G.I., Whitehead, G.W., 1986. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer. J. Pharm. Sci. 75, 356-360.
17. 7]α-melanocyte stimulating hormone: a highly potent α-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. USA 77, 5754-5758.
18. Schmitt, E.A., Flanagan, D.R., Linhardt, R.J., 1993. Degradation and release properties of pellets fabricated from three commercial poly(DL-lactide-co-glycolide) biodegradable polymers. J. Pharm. Sci. 82, 326-329.
19. 7]α-melanocyte-stimulating hormone) in biological matrices. J. Chromatogr. B 670, 235-242.
20. Ugwu, S.O., Blanchard, J., Dorr, R.T., Levine, N., Brooks, C., Hadley, M.E., Aickin, M., Hruby, V.J., 1997. Skin pigmentation and pharmacokinetics of melanotan-I in humans. Biopharm. Drug Dispos. 18, 259-269.
21. Vert, M., Garreau, H., 1995. Recent advances in the field of lactic acid/glycolic acid polymer-based therapeutic systems. Macromol. Symp. 98, 633-642.